ANAMARIA MCCLAUDE: Open Payments
NPI 1134548738 · BRASELTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 9 companies in 2025. Trend: 2023 $524 · 2024 $267 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Lilly USA, LLC | 2 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
Products named: Ozempic, SHINGRIX, MOUNJARO, TZIELD, PAXLOVID, QULIPTA, Rybelsus, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
